Economy

Biogen Inc. (NASDAQ:BIIB) Updates FY17 Earnings Guidance

Biogen Inc. (NASDAQ:BIIB) Updates FY17 Earnings Guidance”

Fisher Asset Mgmt Limited Liability holds 0.05% in Biogen Inc (NASDAQ:BIIB) or 101,887 shares. In looking further ahead, potential investors should note that the company's price to next year's EPS estimates is 12.65.

Several brokerages recently issued reports on BIIB. Alliancebernstein L.P. raised its stake in Biogen by 11.1% in the first quarter. Alliancebernstein L.P. now owns 2,937,319 shares of the biotechnology company's stock valued at $803,122,000 after buying an additional 294,308 shares during the last quarter. Vanguard Group Inc. raised its stake in Biogen by 2.4% in the first quarter. Crestwood Advisors Group LLC purchased a new stake in Biogen during the first quarter valued at approximately $106,000. The institutional investor owned 869 shares of the biotechnology company's stock at the end of the second quarter. Rational Advisors LLC raised its position in shares of Biogen by 14.3% in the first quarter. Another trade for 1,402 shares valued at $380,433 was bought by Vounatsos Michel.

Kazazian Asset Management Llc increased Biogen Inc (BIIB) stake by 189.66% reported in 2016Q4 SEC filing. Moreno Evelyn V now owns 20,470 shares of the biotechnology company's stock valued at $5,596,000 after buying an additional 2,550 shares in the last quarter.

A number of other institutional investors have also modified their holdings of the stock. Biogen has a 52 week low of $244.28 and a 52 week high of $307.76.

Biogen Inc. (NASDAQ:BIIB) updated its FY17 earnings guidance on Tuesday.

Mattel, Inc. (NASDAQ:MAT) stock shows declines of -3.84% and traded at a price of $20.80 in preceding trading session. Shares price isolated positively from its 50 days moving average with 7.58% and remote positively from 200 days moving average with 4.99%.

Biogen (BIIB) clung to gains early Tuesday after its Ionis Pharmaceuticals (IONS)-partnered spinal drug almost tripled expectations in the second quarter, leading to a 4% guidance boost. It had forecast earnings of $20.45 per share to $21.25 per share and revenue of $11.1 billion to $11.4 billion in January. Revenue rose to $3.08 billion from $2.89 billion, compared with the FactSet consensus of $2.81 billion.

Evolving Systems, Inc. (NASDAQ:EVOL) yearly performance is -5.30% and net profit margin is 16.50%. During the same period in the previous year, the firm posted $5.21 EPS. On average, analysts expect that Biogen will post $20.42 EPS for the current fiscal year.

Biogen Inc is a biopharmaceutical company. "(NASDAQ:BIIB)" was published by Transcript Daily and is the property of of Transcript Daily. If you are reading this news story on another domain, it was copied illegally and republished in violation of U.S. & worldwide copyright and trademark legislation. Lakeview Capital Ptnrs Limited has invested 0.24% in Biogen Inc (NASDAQ:BIIB). Robert W. Baird reissued a "neutral" rating and set a $290.00 price target on shares of Biogen in a research report on Wednesday, March 29th. Finally, William Blair restated an "outperform" rating on shares of Biogen in a research report on Monday, June 26th. On Monday, July 17 the stock rating was maintained by BMO Capital Markets with "Hold". Thirteen investment analysts have rated the stock with a hold rating, fourteen have issued a buy rating and two have issued a strong buy rating to the company's stock. Biogen now has a consensus rating of Buy and a consensus price target of $325.48.

In other Biogen news, Director Alexander J. Denner bought 73,858 shares of the firm's stock in a transaction that occurred on Thursday, April 27th. The acquisition was disclosed in a legal filing with the SEC, which is accessible through this hyperlink.

In related news, EVP Susan H. Alexander sold 7,758 shares of the firm's stock in a transaction dated Wednesday, July 19th. The Kazazian Asset Management Llc holds 8,400 shares with $2.38M value, up from 2,900 last quarter. In the past year, Coca-Cola signed an contract to refranchise all existing company-owned bottling operations in China, and reported that it has completed the Coca-Cola European Partners and Coca-Cola Beverages Africa transactions, and the transfer of certain territories in the United States to Arca Continental, and Coke's UNITED bottlers. The disclosure for this sale can be found here. Biogen Inc now has $60.71 billion valuation. Webster Comml Bank N A has 0% invested in Biogen Inc (NASDAQ:BIIB) for 6 shares. At Biogen she will work to drive the uptake of the company's industry-leading portfolio of multiple sclerosis (MS) therapies and raise access for SPINRAZA®, the first and only accepted treatment for spinal muscular atrophy.



Like this

Latest


26 July 2017
AT&T Shares Rise More Than 2% As Company Beats Earnings Expectations
Following the release of the earnings report, the stock was up 2% at $37.00 in the after-hours trading session. The company lost 156,000 satellite subscribers and another 195,000 subscribers of the video U-verse service.

26 July 2017
Tallahassee Ranked In The Top 10 For Most Educated Cities
The Detroit-Warren-Dearborn area came in at number 78 on the list, beating out other cities like Los Angeles and Toledo. The region ranked 32nd for its educational attainment and 69th for its quality of education and attainment gap.

26 July 2017
Teens Charged in Death of 17-Year-Old Boy
Khoury, who was a rising Meade Senior High School senior, met the suspects for an illegal transaction, WRC-TV reported . Johnson is being charged as an adult, and all three teens are being held without the possibility of bail, police said.

26 July 2017
Girl Scouts add STEM badges
But considering Girl Scouts of the United States of America is 1.8 million girls strong, those statistics could change. This will be one of the largest additions to the Girl Scouts' collection since their founding in 1912.

26 July 2017
Meridian Bioscience (NASDAQ:VIVO) Earning Somewhat Favorable News Coverage, Analysis Shows
State Street Corp reported 1.08M shares. 306.07 million shares or 2.07% more from 299.88 million shares in 2016Q3 were reported. The stock's market capitalization is 647.80M. (NYSE:NI) earned "Hold" rating by Argus Research on Tuesday, September 15.

26 July 2017
Century-old building collapses in Kolkata, several feared trapped
It was not properly maintained as well, fire brigade officials said. They were later taken to a nearby hospital for treatment.

26 July 2017
Trudeau: NAFTA dispute resolution system is essential
President Trump has threatened to withdraw from the free trade agreement if a better deal for the USA can not be achieved. Western Canadian producers faced no limits but an export tax between five and 15 per cent depending on lumber prices.

26 July 2017
Kumba Iron Ore reinstates dividend after H1 profit jump
However, Mkhwanazi said there had been a pleasing improvement in productivity. That was in line with what the company had flagged to the market.

26 July 2017
Pembrolizumab fails to improve survival in head and neck squamous cell carcinoma
In the trials, Keytruda was being tested in combination with drugs developed by Celgene ( CELG ), including Pomalyst and Revlimid. Head and neck cancer is a catch-all for various cancers that develop in or around the throat, larynx, nose, sinuses and mouth.

26 July 2017
Death penalty for Pandher, Koli in Pinki Sarkar case
Koli has been sentenced to death for six other murders related to the house, and faces similar charges in nine more instances. However, after taking stock of arguments from both sides the court awarded death sentence to both the accused persons.



Recommended